U.S. markets closed

Kinnevik AB (KNVKF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
56.000.00 (0.00%)
At close: 3:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close56.00
Open56.00
BidN/A x N/A
AskN/A x N/A
Day's Range56.00 - 56.00
52 Week Range16.79 - 56.00
Volume1,900
Avg. Volume350
Market Cap16.09B
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.79 (1.42%)
Ex-Dividend DateAug 25, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Kinnevik: Conference Call to Present First Quarter Results 2021
    GlobeNewswire

    Kinnevik: Conference Call to Present First Quarter Results 2021

    Kinnevik AB (publ) ("Kinnevik") will publish financial results for the first quarter 2021 on Thursday 22 April 2021 at around 08.00 CET. A conference call will be held on the same day at 10.00 CET to present the results. The presentation will be held in English and also be made available via audiocast on Kinnevik’s website, www.kinnevik.com. Link to the audiocast: https://edge.media-server.com/mmc/p/etz7bdh8 Those who wish to participate in the conference call are welcome to dial-in on the below numbers. To ensure that you are connected to the conference call, please dial in and register your attendance a few minutes before the conference call begins. Dial-in numbers: UK: +44 3333000804US: +1 6319131422SE: +46 856642651 Confirmation code: 33385260# For further information, visit www.kinnevik.com or contact: Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B. Attachment Press release

  • Kinnevik emerges as the largest shareholder in Kolonial after particpating in a funding round co-led by Softbank and Prosus
    GlobeNewswire

    Kinnevik emerges as the largest shareholder in Kolonial after particpating in a funding round co-led by Softbank and Prosus

    Kinnevik AB (publ) ("Kinnevik”) today announced its participation with NOK 200m in Kolonial’s recent funding round. The NOK 2.2bn round was co-led by Softbank and Prosus, and encompassed NOK 1.2bn in primary equity and NOK 1.0bn in secondary equity acquired from other existing shareholders. After the round, Kinnevik emerges as the largest shareholder in Kolonial, owning 21% of the company. The newly raised capital will be used to fund Kolonial’s international expansion plans, beginning with Finland, with a new fulfilment center due to open in Helsinki later this year. The company is further in the earlier stages of preparing a 2022 launch in the EUR 220bn German grocery market. In preparation of becoming a global company and the imminent international expansion, Kolonial is refreshing its brand proposition and changing its name to Oda. Oda’s mission is to be the most effective online grocer in the world, and it has world leading picking efficiency of 212 UPH (units processed per labor hour at the warehouse), compared to 169 UPH of the leading UK online grocer in 2020. Its unique business model is built on Nordic principles of employee wellbeing and a commitment to sustainability, as well as proprietary warehouse automation and data-driven processes. Georgi Ganev, CEO of Kinnevik commented:” We are excited by the strong traction in Oda and its international expansion plans. Since our first investment in 2018, Karl and his team have consistently impressed us with their combined focus on growth and efficiency, achieving world class productivity levels in their fulfilment operations. We are happy to welcome fellow leading global tech investors Softbank and Prosus as shareholders, and we look forward to working with them in support of Oda’s growth plans and international expansion.” In Kinnevik’s Year-End Release 2020, Kinnevik’s investment in Oda was valued at SEK 1,087m. Out of Kinnevik’s approximate NOK 200m participation in the new funding round, some 170m were injected already in 2019 in the form of a convertible bridge note, converting into shares at a customary discount to the valuation in the funding round. During the last months, Oda has consistently beaten its budgeted growth, set new record levels in fulfilment efficiency, and made significant strides in its preparations for international expansion. These developments, in combination with the new funding round, which values the business at NOK 7.5bn post-money, provide strong reference points for a valuation of Kinnevik’s investment in Oda that would correspond to a value uplift of more than 40 percent to just below SEK 1.6bn. For further information, visit www.kinnevik.com or contact: Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B. Attachment Pressrelease

  • Walgreens-Backed VillageMD Plans Initial Public Offering
    Bloomberg

    Walgreens-Backed VillageMD Plans Initial Public Offering

    (Bloomberg) -- VillageMD, a primary health-care provider backed by Walgreens Boots Alliance Inc., is planning to go public in the U.S. in an initial public offering, according to people with knowledge of the matter.The company, founded in 2013, plans to raise more than $500 million in a listing that could happen in the third quarter, the people said, asking not to be identified because the information is private. The IPO could raise as much as $1 billion and value the company at up to $10 billion, one of the people said.Health-care and health-tech deals have fared well despite market volatility in the past year as the global pandemic lured more investments into the sector. Another primary-care service provider, Agilon Health Inc., filed on Wednesday to raise as much as $1.1 billion in a U.S. IPO. Two of the four blank-check mergers announced this week involve health-care companies.A representative for VillageMD didn’t immediately respond to a request for comment.VillageMD operates its own clinics under the brand name Village Medical and also partners with independent providers, according to its website. Some of its offices are located inside Walgreens stores under a partnership with the drugstore chain.The company, which operates in 12 U.S. markets, raised $100 million in 2019in a series B financing round from Swedish investor Kinnevik AB, Oak HC/FT, Town Hall Ventures and Adams Street Partners, according to a company statement at the time.Kinnevik valued its 9% stake in the company at 4.84 billion Swedish kronor ($561 million) as of Dec. 31, according to a filing. That implies a current valuation of $6.2 billion for VillageMD.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.